Titel

Merkliste
1 Ergebnisse

Distinguishing features of a novel humanized anti-EGFR mono..:

Pei-Hua Lin (11681535) ; Chi-Ling Tseng (11681538) ; Yun-Chih Cheng (11681541)...
https://figshare.com/articles/journal_contribution/Distinguishing_features_of_a_novel_humanized_anti-EGFR_monoclonal_antibody_based_on_cetuximab_with_superior_antitumor_efficacy/16990092. , 2021

Link: https://doi.org/10.6084/m9.figshare.16990092.v1

RT Journal
T1 <Title>Distinguishing features of a novel humanized anti-EGFR monoclonal antibody based on cetuximab with superior antitumor efficacy</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16990092&Exemplar=1&LAN=DE
				
A1 Pei-Hua Lin (11681535)
A1 Chi-Ling Tseng (11681538)
A1 Yun-Chih Cheng (11681541)
A1 Chieh-Hsin Ho (11681544)
A1 Shih Chieh Chen (11681547)
A1 Yanling Wang (309043)
A1 Eugene Liu (1271409)
A1 Hassan Issafras (11681550)
A1 Weidong Jiang (468041)
YR 2021
K1 Medicine
K1 Genetics
K1 Pharmacology
K1 Biotechnology
K1 Immunology
K1 Developmental Biology
K1 Cancer
K1 Science Policy
K1 Infectious Diseases
K1 Space Science
K1 Biological Sciences not elsewhere classified
K1 Chemical Sciences not elsewhere classified
K1 EGFR
K1 cetuximab
K1 monoclonal antibody (mAb)
K1 safety
K1 humanization
K1 antibody-dependent cell mediated cytotoxicity (ADCC)
K1 NSCLC
K1 combination therapy
K1 PD-1
K1 HLX07
JF https://figshare.com/articles/journal_contribution/Distinguishing_features_of_a_novel_humanized_anti-EGFR_monoclonal_antibody_based_on_cetuximab_with_superior_antitumor_efficacy/16990092
LK http://dx.doi.org/https://doi.org/10.6084/m9.figshare.16990092.v1
DO https://doi.org/10.6084/m9.figshare.16990092.v1
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)